Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
[Association between depression and cognitive decline in sclerosis multiplex patients].
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells.
A manual of diseases of the nervous system
Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis.
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States.
Pathology and disease mechanisms in different stages of multiple sclerosis.
Neutralizing Nanobodies targeting diverse chemokines effectively inhibit chemokine function.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety.
Effects of vitamin d3, calcipotriol and FTY720 on the expression of surface molecules and cytolytic activities of human natural killer cells and dendritic cells.
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.
Influence of treatments in multiple sclerosis disability: A cohort study.
MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan.
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Information regarding Active Biotech's candidate drug laquinimod
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance.

Pages